Home532296 • BOM
add
Glenmark Pharmaceuticals Ltd
Previous close
₹2,015.45
Day range
₹2,000.55 - ₹2,039.00
Year range
₹1,274.70 - ₹2,286.15
Market cap
574.39B INR
Avg Volume
13.50K
P/E ratio
54.00
Dividend yield
0.18%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 39.01B | 15.15% |
Operating expense | 18.90B | 3.53% |
Net income | 4.03B | 15.88% |
Net profit margin | 10.34 | 0.68% |
Earnings per share | 19.21 | -7.33% |
EBITDA | 7.80B | 36.09% |
Effective tax rate | 24.49% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.90B | 47.80% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 95.82B | — |
Shares outstanding | 282.16M | — |
Price to book | 5.94 | — |
Return on assets | — | — |
Return on capital | 16.55% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 4.03B | 15.88% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Wikipedia
Founded
Nov 18, 1977
Website
Employees
15,800
